Leonid Gibiansky

3.1k total citations
90 papers, 2.2k citations indexed

About

Leonid Gibiansky is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Leonid Gibiansky has authored 90 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Leonid Gibiansky's work include Monoclonal and Polyclonal Antibodies Research (29 papers), Composite Material Mechanics (20 papers) and Lymphoma Diagnosis and Treatment (17 papers). Leonid Gibiansky is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (29 papers), Composite Material Mechanics (20 papers) and Lymphoma Diagnosis and Treatment (17 papers). Leonid Gibiansky collaborates with scholars based in United States, Switzerland and United Kingdom. Leonid Gibiansky's co-authors include Ekaterina Gibiansky, Salvatore Torquato, Ole Sigmund, Andrej Cherkaev, Peiming Ma, Tarundeep Kakkar, Graeme W. Milton, Matthew J. Silva, L.J. Gibson and Nicolas Frey and has published in prestigious journals such as Journal of Geophysical Research Atmospheres, Blood and Journal of Applied Physics.

In The Last Decade

Leonid Gibiansky

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonid Gibiansky United States	27	768	483	395	381	371	90	2.2k
Naoyuki Watanabe Japan	33	1.1k 1.5×	585 1.2×	412 1.0×	323 0.8×	166 0.4×	156	3.4k
Jeff Wang China	33	638 0.8×	432 0.9×	254 0.6×	70 0.2×	272 0.7×	130	3.8k
Junji Kato Japan	26	561 0.7×	414 0.9×	85 0.2×	787 2.1×	88 0.2×	148	2.7k
Xiaolong Fu China	31	519 0.7×	748 1.5×	334 0.8×	298 0.8×	740 2.0×	193	3.1k
Timothy C. Kennedy United States	25	294 0.4×	133 0.3×	409 1.0×	114 0.3×	309 0.8×	89	2.4k
Paolo Zunino Italy	28	334 0.4×	147 0.3×	98 0.2×	26 0.1×	43 0.1×	136	2.5k
Hong Zheng China	31	199 0.3×	265 0.5×	852 2.2×	12 0.0×	776 2.1×	153	3.2k
Takao Endo Japan	30	148 0.2×	245 0.5×	1.2k 3.1×	135 0.4×	950 2.6×	198	4.3k
Yu Shi China	25	43 0.1×	737 1.5×	530 1.3×	30 0.1×	577 1.6×	184	2.5k
Sang Joon Shin South Korea	37	52 0.1×	350 0.7×	1.3k 3.3×	49 0.1×	2.7k 7.2×	280	5.0k

Countries citing papers authored by Leonid Gibiansky

Since Specialization

Citations

This map shows the geographic impact of Leonid Gibiansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Gibiansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Gibiansky more than expected).

Fields of papers citing papers by Leonid Gibiansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Gibiansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Gibiansky. The network helps show where Leonid Gibiansky may publish in the future.

Co-authorship network of co-authors of Leonid Gibiansky

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Gibiansky. A scholar is included among the top collaborators of Leonid Gibiansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Gibiansky. Leonid Gibiansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Tommy, Leonid Gibiansky, Apurvasena Parikh, et al.. (2025). Optimal Dosing Regimen for Epcoritamab, a Subcutaneous Bispecific Antibody, in Relapsed or Refractory Large B‐Cell Lymphoma. Clinical Pharmacology & Therapeutics. 117(5). 1437–1450. 1 indexed citations

Jamois, Candice, David C. Turner, Leonid Gibiansky, et al.. (2025). Tocilizumab Dosing for Management of T Cell‐Engaging Bispecific Antibody‐Related CRS in Patients With R/R B‐Cell NHL. Clinical Pharmacology & Therapeutics. 118(4). 917–927. 1 indexed citations

Li, Tommy, Leonid Gibiansky, Apurvasena Parikh, et al.. (2024). Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Clinical Pharmacokinetics. 64(1). 127–141. 2 indexed citations

Avery, Robert L., Chui Ming Gemmy Cheung, Karl G. Csaky, et al.. (2024). Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema. Translational Vision Science & Technology. 13(11). 13–13. 4 indexed citations

Li, Tommy, Leonid Gibiansky, Apurvasena Parikh, et al.. (2023). Population Pharmacokinetics of Subcutaneous Epcoritamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 142(Supplement 1). 4481–4481. 1 indexed citations

Plowchalk, David R., et al.. (2023). Population PK/PD modeling of low‐density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti‐PCSK9 monoclonal antibody. CPT Pharmacometrics & Systems Pharmacology. 12(12). 2013–2026. 5 indexed citations

Passey, Chaitali, Jenna L. Voellinger, Leonid Gibiansky, et al.. (2023). Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1262–1273. 8 indexed citations

Liao, Michael Z., Rong Deng, Leonid Gibiansky, et al.. (2023). Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX. Clinical and Translational Science. 16(12). 2744–2755. 3 indexed citations

Lemenuel‐Diot, Annabelle, Kashyap Patel, Leonid Gibiansky, et al.. (2020). Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization. British Journal of Clinical Pharmacology. 87(3). 1359–1368. 3 indexed citations

10.

Cai, Weiguo, Tarek A. Leil, Leonid Gibiansky, et al.. (2020). Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon‐γ–Induced Protein 10, BMS‐986184, in Healthy Participants to Guide Therapeutic Dosing. Clinical Pharmacology in Drug Development. 9(6). 689–698. 3 indexed citations

11.

Gibiansky, Leonid, et al.. (2020). Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants. Clinical Pharmacology & Therapeutics. 108(1). 126–135. 4 indexed citations

12.

Gibiansky, Ekaterina, Leonid Gibiansky, Nicolas Frey, et al.. (2019). Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study. British Journal of Clinical Pharmacology. 85(9). 1935–1945. 7 indexed citations

13.

Deng, Rong, Leonid Gibiansky, Tong Lu, et al.. (2019). Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study. Leukemia & lymphoma. 61(1). 56–65. 9 indexed citations

14.

Gibiansky, Leonid, Craig R. Rayner, Barbara J. Brennan, et al.. (2015). Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment. Journal of Pharmacokinetics and Pharmacodynamics. 42(3). 225–236. 10 indexed citations

15.

Gibiansky, Leonid, Ekaterina Gibiansky, & Robert J. Bauer. (2011). Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model. Journal of Pharmacokinetics and Pharmacodynamics. 39(1). 17–35. 29 indexed citations

16.

Gibiansky, Leonid & Ekaterina Gibiansky. (2009). Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics. Expert Opinion on Drug Metabolism & Toxicology. 5(7). 803–812. 87 indexed citations

17.

Gibiansky, Ekaterina, Michel Struys, Leonid Gibiansky, et al.. (2005). AQUAVANO (R) injection, a water-soluble prodrug of propofol, as a bolus injection. Anesthesiology. 103(4). 718–729. 18 indexed citations

18.

Gibiansky, Leonid & Salvatore Torquato. (1996). Connection between the conductivity and bulk modulus of isotropic composite materials. Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences. 452(1945). 253–283. 73 indexed citations

19.

Cherkaev, Andrej & Leonid Gibiansky. (1996). Extremal structures of multiphase heat conducting composites. International Journal of Solids and Structures. 33(18). 2609–2623. 21 indexed citations

20.

Gibiansky, Leonid & Graeme W. Milton. (1993). On the effective viscoelastic moduli of two-phase media. I. Rigorous bounds on the complex bulk modulus. Proceedings of the Royal Society of London Series A Mathematical and Physical Sciences. 440(1908). 163–188. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact